Abstract:Background Stroke is the second leading cause of mortality and disability in the world. Post-stroke rehabilitation is still unsatisfactory in clinics, which brings giant pains and economic burdens to stroke patients. In this study, an injectable hydrogel where tannic acid (TA) acts as not only a building block but a therapeutic drug was developed for post-stroke rehabilitation. Methods TA is used as a building block to form an injectable hydrogel (TA-gel) with carboxymethyl chitosan (CMCS) by multivalent hydrogen bonds. The morphology, rheological property, and TA release behavior of the hydrogel were characterized. The abilities of the TA-gel to modulate microglia (BV2 cells) polarization and subsequently enhance the neuroplasticity of neuro cells (N2A cells) were assessed in vitro. The TA-gel was injected into the cavity of the stroke mouse for the evaluation of motor function recovery, microglial polarization, and neuroplasticity in vivo. The investigation of the molecular pathway through which TA modulates microglia polarization was also explored both in vitro and in vivo. Results The TA-gel exhibited a sustainable released behavior of TA. It can suppress the expression of CD16 and IL-1β, and upgrade the expression of CD206 and TGF-β in the oxygen and glucose-deprived (OGD) BV2 cell, indicating the regulation of OGD BV2 cells to anti-inflammatory phenotype in vitro. It further shows the decrease of synaptophysin and PSD95 in the OGD N2a cells is effectively recovered by the anti-inflammatory BV2 cells. Furthermore, it showed the TA-gel can decrease the CD16/iNOS expression, and increase the CD206 expression in the peri-infarct area of stroke mice, implying anti-inflammatory polarization of microglia in vivo. The colocalization of PSD95 and Vglut-1 stains as well as the Golgi stain showed the enhancement of neuroplasticity by the TA-gel. Spontaneously, the TA-gel successfully recovered the motor function of stroke mice. The western blot results in vitro and in vivo suggested TA-gel regulated microglia polarization via the NF-κB pathway. Conclusion The TA gel serves as an effective brain injectable implant to treat stroke and shows promising potential to promote post-stroke rehabilitation in the clinic.

ROS-scavenging Microgels Containing PTPσ Receptor Modulatory Peptides Synergistically Alleviate Inflammation and Promote Functional Recovery Post Stroke

Novel multi-drug delivery hydrogel using scar-homing liposomes improves spinal cord injury repair.

Curcumin loaded hydrogel with double ROS-scavenging effect regulates microglia polarization to promote poststroke rehabilitation

Multifunctional Injectable Hydrogel Promotes Functional Recovery after Stroke by Modulating Microglial Polarization, Angiogenesis and Neuroplasticity

Dual-function Hydrogels with Sequential Release of GSK3β Inhibitor and VEGF Inhibit Inflammation and Promote Angiogenesis after Stroke

A Combined Strategy of Brain Neuroprotection and Endogenous Neuroregeneration for Enhanced Intracerebral Hemorrhage Treatment Via an Injectable Biomimetic Hydrogel with Efficient ROS Scavenging and Therapeutics Delivery

An Injectable Ros-Responsive Hydrogel Containing Cycloastragenol Promotes Functional Recovery in Spinal Cord Contusion Rats by Repairing the Blood-Spinal Cord Barrier

Inhibition of CSPG receptor PTPσ promotes migration of newly born neuroblasts, axonal sprouting, and recovery from stroke

ROS‐Scavenging Hydrogels Synergize with Neural Stem Cells to Enhance Spinal Cord Injury Repair via Regulating Microenvironment and Facilitating Nerve Regeneration

Remodeling brain pathological microenvironment to lessen cerebral ischemia injury by multifunctional injectable hydrogels

Surface-tethered ROS-responsive Micelle Backpacks for Boosting Mesenchymal Stem Cell Vitality and Modulating Inflammation in Ischemic Stroke Treatment.

A reactive oxygen species-responsive hydrogel encapsulated with bone marrow derived stem cells promotes repair and regeneration of spinal cord injury

ROS-responsive 18β-glycyrrhetic acid-conjugated polymeric nanoparticles mediate neuroprotection in ischemic stroke through HMGB1 inhibition and microglia polarization regulation

Dynamically Crosslinked ECM-like Hydrogels Loaded with ROS-responsive Drug Nanoparticles for Treating Inflammation in Myocardial Infarction and Stroke

A Homing Peptide Modified Neutrophil Membrane Biomimetic Nanoparticles in Response to ROS/inflammatory Microenvironment for Precise Targeting Treatment of Ischemic Stroke

Reactive Oxide Species-Scavenging Lipid-Polymer Nanoparticles for Neuroprotection after Spinal Cord Injury

Tannic acid as building block constructing injectable hydrogel and regulating microglial phenotype to enhance neuroplasticity for post-stroke rehabilitation

Macrophage membrane-modified reactive oxygen species-responsive prodrug self-assembled nanoparticles for the targeted treatment of traumatic spinal cord injury

Scar Tissue-Targeting Polymer Micelle for Spinal Cord Injury Treatment

ROS-scavenging hybrid hydrogel for genetically engineered stem cell delivery and limb ischemia therapy

Hypoxia-responsive Calixarene-Grafted Self-Assembled Peptide Hydrogel for Inflammation Suppression in Ischemic Stroke